These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2000218)

  • 21. N-methyl-N-nitrosourea-induced transformation of rat urothelial cells in vitro is not mediated by activation of ras oncogenes.
    Knowles MA; Eydmann ME; Proctor A; Padua RA; Roberts J
    Oncogene; 1987 May; 1(2):143-8. PubMed ID: 3325878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
    Fernandez A; Chen PW; Ananthaswamy HN
    Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of the neoplastic phenotype of EBV-established B lymphocytes by the human Ha-ras oncogene.
    Nasi S; Sirinian MI; Panetta G; Marchetti A; Jucker R
    Oncogene; 1990 Jan; 5(1):117-22. PubMed ID: 2157177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation of an infinite life span human fibroblast cell strain by transfection with v-Ki-ras.
    Fry DG; Milam LD; Dillberger JE; Maher VM; McCormick JJ
    Oncogene; 1990 Sep; 5(9):1415-8. PubMed ID: 2216465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
    Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
    Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.
    McCormick JJ; Fry DG; Hurlin PJ; Morgan TL; Wilson DM; Maher VM
    Prog Clin Biol Res; 1990; 340D():195-205. PubMed ID: 2196579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mutations affecting Na+: H+ antiport activity on tumorigenic potential of hamster lung fibroblasts.
    Lagarde AE; Franchi AJ; Paris S; Pouysségur JM
    J Cell Biochem; 1988 Mar; 36(3):249-60. PubMed ID: 2837494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
    Denner J; Ehm I; Jandrig B; Friese D
    Arch Geschwulstforsch; 1987; 57(6):463-74. PubMed ID: 3435225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous in vitro transformation of human fibroblasts.
    Mukherji B; MacAlister TJ; Guha A; Gillies CG; Jeffers DC; Slocum SK
    J Natl Cancer Inst; 1984 Sep; 73(3):583-93. PubMed ID: 6590910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC
    Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological transformation, focus formation, and anchorage independence induced in diploid human fibroblasts by expression of a transfected H-ras oncogene.
    Hurlin PJ; Fry DG; Maher VM; McCormick JJ
    Cancer Res; 1987 Nov; 47(21):5752-7. PubMed ID: 2444334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary transfection as a mechanism for transformation of host cells by human tumor cells implanted in nude mice.
    Gupta V; Rajaraman S; Gadson P; Costanzi JJ
    Cancer Res; 1987 Oct; 47(19):5194-201. PubMed ID: 3621205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.
    Arends MJ; McGregor AH; Wyllie AH
    Am J Pathol; 1994 May; 144(5):1045-57. PubMed ID: 8178928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of rodent immortalized and embryo cells by oncogenes. II. Rat embryo fibroblasts (REF).
    Denner J; Jandrig B; Ehm I; Schramm T
    Arch Geschwulstforsch; 1987; 57(6):475-85. PubMed ID: 3435226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
    Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
    Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stat1 expression is not sufficient to regulate the interferon signaling pathway in cellular immortalization.
    Tang L; Roberts PC; Kraniak JM; Li Q; Tainsky MA
    J Interferon Cytokine Res; 2006 Jan; 26(1):14-26. PubMed ID: 16426144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.